Atopic Dermatitis / USA /$170.10 + $127 / Ends 30th September
This study is for the US, to learn more about the experience of people living individuals with Atopic Dermatitis (AD), including experiences of AD symptoms, flares and remission, and to gather feedback on questionnaires that measure AD symptom experiences.


Time & Location
01 Jul 2024, 13:00 BST – 30 Aug 2024, 18:00 BST
Zoom
Study objectives
This study is for the US, to learn more about the experience of people living individuals with Atopic Dermatitis (AD), including experiences of AD symptoms, flares and remission, and to gather feedback on questionnaires that measure AD symptom experiences.
The study will consist of one or two telephone or Microsoft Teams® teleconference interviews about 2 to 3 months apart. The first interview is expected to last up to 90 minutes while the second is expected to last up to 60 minutes
As a token of our appreciation for your time, those participating will receive approximately $170.10 after completion of the first interview and $127 after completion of the second interview.